Targeted alpha PSMA-based therapy of metastatic castrate-resistant prostate-cancer patients (mCRPC): prediction dosimetry
- Resource Type
- Source
- Physica Medica. 92:S89
- Subject
Biophysics General Physics and Astronomy Radiology, Nuclear Medicine and imaging General Medicine - Language
- ISSN
- 1120-1797